Video
Lack of guidelines creates high rates of missed Lynch syndrome diagnosis in UTUC
Author(s):
“We found that while the NCCN guideline for Lynch syndrome is highly specific in identifying patients with Lynch syndrome, it missed about 50% of patients with upper tract cancer who had Lynch syndrome,” says Hong Truong, MD.
Video Player is loading.
In this video, Hong Truong, MD,discusses the findings of the study, “Defining hereditary upper tract urothelial carcinoma: Implications for genetic testing and clinical management,” which was presented at the 2022 ASCO Genitourinary Cancers Symposium. Truong is a urologic oncology fellow at Memorial Sloan Kettering Cancer Center in New York, New York.
Related Videos
Joy Maulik, CRNP, on the importance of genetic testing in prostate cancer
Paul Sieber, MD, on the future of genetic testing in prostate cancer
Daniel Kwon, MD, discusses study’s impact on veteran access to germline testing for prostate cancer
Tim Richardson, MD, on genetic testing in the era of targeted therapies
Discussing germline testing for prostate cancer with veterans
Kara Cossis, PA-C, MPH, on the role of APPs in genetic testing
Tim A. Richardson, MD, outlines key settings for genetic testing in prostate cancer
Germline testing study’s implications for veteran access to prostate cancer treatments
Kara Cossis, PA-C, MPH, on challenges, opportunities with genetic testing
Daniel Kwon, MD, on germline testing for prostate cancer in veterans with service-connected benefits
Related Content
